Navigation Links
Kansas Bioscience Authority Approves $700,000 in Investments

OLATHE, Kan., Nov. 20, 2012 /PRNewswire/ -- The Kansas Bioscience Authority board of directors today approved $700,000 in new investments. The investments are:

  • Parnell, an Australian veterinary pharmaceutical company, received a $400,000 grant to support the company's move to establish a North American headquarters in the Kansas City Animal Health Corridor. The grant will help to defray the company's hiring during the next year of 14 new employees with an average annual wage of $150,000.
  • A $300,000 grant will support the establishment in Kansas of a contract research organization by a firm established elsewhere in the country. The company expects to create 16 new jobs at its proposed Kansas site, with an average salary of $65,000 a year, as well as to attract new federal, state and privately funded research projects. The company also plans to work with Kansas research institutions to advance research and commercialization activities. The KBA has agreed to hold confidential the identity of the company pending the completion of certain negotiations related to its relocation to Kansas.

Approved investments are subject to final agreements between the Kansas Bioscience Authority and investees, with payments made only as the recipients achieve specified milestones.

About the KBA
The Kansas Bioscience Authority was created by the Kansas Economic Growth Act of 2004 to accelerate growth in the bioscience sector. Funded by Kansas income taxes generated by bioscience jobs, KBA investments help create high-paying jobs, fuel capital expenditures, spur outside grants, and encourage private capital investments in Kansas bioscience companies. KBA investments result in high-quality jobs today and for future generations of Kansans, and bioscience discoveries and life-saving cures that will improve lives around the world.

For more information, contact:
Justin LaBerge, APR
785.766.5688 (mobile) or

SOURCE Kansas Bioscience Authority
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
2. Auditors Complete Kansas Bioscience Authority Forensic Audits
3. Netsmart Selects Overland Park, Kansas, for New Office
4. Heartland Plant Innovations Wins Kansas Bioscience Authority Funding
5. Cantrell Selected to Lead Kansas Bioscience Authority
6. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
7. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
8. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
9. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
10. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
11. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
Post Your Comments:
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):